Analyst Activity – Jefferies Group Initiates Coverage On NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS) With a Buy

ME Staff
-
0

Analyst Ratings For NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS)

Today, Jefferies Group initiated coverage on NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy with a price target of $17.00.

Some recent analyst ratings include

  • 6/5/2018-Jefferies Group initiated coverage with a Buy rating.
  • 3/2/2018-Cowen Reiterated Rating of Buy.
  • 8/23/2017-Credit Suisse Group Upgrade from a “Underperform ➝ Neutral” rating to a “” rating.
  • 8/8/2017-Wedbush Reiterated Rating of Outperform.
  • 4/5/2017-Cantor Fitzgerald Reiterated Rating of Buy.

Recent Insider Trading Activity For NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS)
NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS) has insider ownership of 39.50% and institutional ownership of 86.61%.

  • On 3/12/2018 Adams Street Partners Llc, Major Shareholder, bought 588,235 with an average share price of $8.50 per share and the total transaction amounting to $4,999,997.50.
  • On 3/12/2018 Richard A Md Miller, CEO, bought 100,000 with an average share price of $8.50 per share and the total transaction amounting to $850,000.00.
  • On 11/20/2017 Richard A Md Miller, CEO, bought 10,000 with an average share price of $10.79 per share and the total transaction amounting to $107,900.00.
  • On 6/23/2017 Holdings A/S Novo, Major Shareholder, bought 20,000 with an average share price of $10.95 per share and the total transaction amounting to $219,000.00.
  • On 6/13/2017 Richard A Md Miller, Insider, bought 25,000 with an average share price of $9.88 per share and the total transaction amounting to $247,000.00.
  • On 6/24/2016 Orbimed Advisors Llc, Director, bought 1,000 with an average share price of $12.98 per share and the total transaction amounting to $12,980.00.
  • On 6/21/2016 Orbimed Advisors Llc, Director, bought 38,383 with an average share price of $12.75 per share and the total transaction amounting to $489,383.25.

Recent Trading Activity for NASDAQ:CRVS – Corvus Pharmaceuticals (NASDAQ:CRVS)
Shares of NASDAQ:CRVS – Corvus Pharmaceuticals closed the previous trading session at 12.08 up +0.52 4.54% with 12.09000015258789 shares trading hands.